Trial intelligence / Profile preview

Ulinastatin in Complicated Intra-Abdominal Infection

NCT07672496Not yet recruiting

Sponsor
Fujian Medical University Union Hospital
Start
Oct 2026
Primary completion
Dec 2027
Countries
1
01

Overview

Randomised, single-blind trial of ulinastatin in Intra-abdominal infection (IAI) (3 arms), sponsored by Fujian Medical University Union Hospital. Primary endpoint: Systemic Immune-Inflammation Index at Day 5. Planned start Oct 2026; status: not yet recruiting.

02

Drugs

ulinastatin
03

Conditions

Intra-abdominal infection (IAI)

Beyond the preview

Go deeper on NCT07672496.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07672496.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call